{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:29:35Z","timestamp":1791894575115,"version":"4.3.4"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.diagmicrobio.2026.117345","type":"journal-article","created":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T20:02:46Z","timestamp":1772308966000},"page":"117345","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Investigation of the cefazolin inoculum effect in blood culture-isolated methicillin-susceptible Staphylococcus aureus strains: A Japanese multicenter study"],"prefix":"10.1016","volume":"115","author":[{"given":"Shinnosuke","family":"Fukushima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuma","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyoshi","family":"Gotoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Iio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakura","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihito","family":"Koyanagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Koganemaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5086-1891","authenticated-orcid":false,"given":"Hideharu","family":"Hagiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2026.117345_bib0001","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1128\/CMR.00134-14","article-title":"Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management","volume":"28","author":"Tong","year":"2015","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.diagmicrobio.2026.117345_bib0002","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1017\/S0950268816000613","article-title":"Burden of community-onset bloodstream infections, Western Interior, British Columbia, Canada","volume":"144","author":"Laupland","year":"2016","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.diagmicrobio.2026.117345_bib0003","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2021.26.46.2002094","article-title":"Staphylococcus aureus bloodstream infections: diverging trends of meticillin-resistant and meticillin-susceptible isolates, EU\/EEA, 2005 to 2018","volume":"26","author":"Gagliotti","year":"2021","journal-title":"Euro Surveill"},{"key":"10.1016\/j.diagmicrobio.2026.117345_bib0004","doi-asserted-by":"crossref","first-page":"214","DOI":"10.15585\/mmwr.mm6809e1","article-title":"Vital signs: epidemiology and recent trends in methicillin-resistant and in methicillin-susceptible Staphylococcus aureus bloodstream infections - United States","volume":"68","author":"Kourtis","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.diagmicrobio.2026.117345_bib0005","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/cid\/cix287","article-title":"Comparative effectiveness of Cefazolin versus Nafcillin or Oxacillin for treatment of methicillin-susceptible Staphylococcus aureus infections complicated by bacteremia: a nationwide cohort study","volume":"65","author":"McDanel","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2026.117345_bib0006","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1111\/j.1469-0691.2010.03425.x","article-title":"Are all beta-lactams similarly effective in the treatment of methicillin-sensitive Staphylococcus aureus bacteraemia?","volume":"17","author":"Paul","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.diagmicrobio.2026.117345_bib0007","doi-asserted-by":"crossref","first-page":"dlae069","DOI":"10.1093\/jacamr\/dlae069","article-title":"Clinical significance of cefazolin inoculum effect in serious MSSA infections: a systematic review","volume":"6","author":"Lo","year":"2024","journal-title":"JAC Antimicrob Resist"},{"key":"10.1016\/j.diagmicrobio.2026.117345_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.diagmicrobio.2024.116399","article-title":"Cefazolin inoculum effect in methicillin-susceptible Staphylococcus aureus clinical isolates","volume":"110","author":"Tsuji","year":"2024","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2026.117345_bib0009","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1093\/jac\/dkz226","article-title":"Inoculum effect of \u03b2-lactam antibiotics","volume":"74","author":"Lenhard","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2026.117345_bib0010","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00324-17","article-title":"Efficacy of ceftaroline against methicillin-susceptible Staphylococcus aureus exhibiting the cefazolin high-inoculum effect in a rat model of endocarditis","volume":"61","author":"Singh","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2026.117345_bib0011","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1093\/jac\/dkaf065","article-title":"In vivo evaluation of cefazolin inoculum effect in the treatment of experimental Staphylococcus aureus pneumonia with cefazolin","volume":"80","author":"Lee","year":"2025","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2026.117345_bib0012","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1128\/AAC.00317-09","article-title":"Inoculum effect with cefazolin among clinical isolates of methicillin-susceptible Staphylococcus aureus: frequency and possible cause of cefazolin treatment failure","volume":"53","author":"Nannini","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2026.117345_bib0013","doi-asserted-by":"crossref","first-page":"ofy123","DOI":"10.1093\/ofid\/ofy123","article-title":"The cefazolin inoculum effect is associated with increased mortality in methicillin-susceptible Staphylococcus aureus bacteremia","volume":"5","author":"Miller","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2026.117345_bib0014","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00382-18","article-title":"Prevalence of a cefazolin inoculum effect associated with blaZ gene types among methicillin-susceptible Staphylococcus aureus isolates from four major medical centers in Chicago","volume":"62","author":"Wang","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2026.117345_bib0015","doi-asserted-by":"crossref","first-page":"e02511","DOI":"10.1128\/AAC.02511-19","article-title":"Novel insights into the classification of staphylococcal \u03b2-lactamases in relation to the cefazolin inoculum effect","volume":"64","author":"Carvajal","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2026.117345_bib0016","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1093\/jac\/dkt254","article-title":"Cefazolin high-inoculum effect in methicillin-susceptible Staphylococcus aureus from South American hospitals","volume":"68","author":"Rinc\u00f3n","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2026.117345_bib0017","doi-asserted-by":"crossref","DOI":"10.1128\/jcm.02495-21","article-title":"Prevalence and characterization of the cefazolin inoculum effect in North American methicillin-susceptible Staphylococcus aureus isolates","volume":"60","author":"Dingle","year":"2022","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2026.117345_bib0018","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3947\/ic.2019.51.4.376","article-title":"The cefazolin inoculum effect and the presence of type A blaZ gene according to agr genotype in methicillin-susceptible Staphylococcus aureus bacteremia","volume":"51","author":"Lee","year":"2019","journal-title":"Infect Chemother"},{"key":"10.1016\/j.diagmicrobio.2026.117345_bib0019","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jiac.2017.10.021","article-title":"Inoculum effect of high concentrations of methicillin-susceptible Staphylococcus aureus on the efficacy of cefazolin and other beta-lactams","volume":"24","author":"Saeki","year":"2018","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.diagmicrobio.2026.117345_bib0020","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01938-20","article-title":"A test for the rapid detection of the cefazolin inoculum effect in methicillin-susceptible Staphylococcus aureus","volume":"59","author":"Rincon","year":"2021","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2026.117345_bib0021","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00898-24","article-title":"Prevalence of the cefazolin inoculum effect (CzIE) in nasal colonizing methicillin-susceptible Staphylococcus aureus in patients from intensive care units in Colombia and use of a modified rapid nitrocefin test for detection","volume":"68","author":"Carvajal","year":"2024","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2026.117345_bib0022","series-title":"M100 performance standards for antimicrobial susceptibility testing. M100-Ed32","year":"2022"},{"key":"10.1016\/j.diagmicrobio.2026.117345_bib0023","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1128\/CMR.8.4.557","article-title":"Beta-lactamases in laboratory and clinical resistance","volume":"8","author":"Livermore","year":"1995","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.diagmicrobio.2026.117345_bib0024","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1086\/379021","article-title":"Relapse of type A beta-lactamase-producing Staphylococcus aureus native valve endocarditis during cefazolin therapy: revisiting the issue","volume":"37","author":"Nannini","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2026.117345_bib0025","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1128\/AAC.42.12.3163","article-title":"Characterization of a chromosomal gene encoding type B \u03b2-lactamase in phage group II isolates of Staphylococcus aureus","volume":"42","author":"Voladri","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2026.117345_bib0026","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3343\/alm.2018.38.2.155","article-title":"Prevalence of blaZ gene and performance of phenotypic tests to detect penicillinase in Staphylococcus aureus isolates from Japan","volume":"38","author":"Takayama","year":"2018","journal-title":"Ann Lab Med"},{"key":"10.1016\/j.diagmicrobio.2026.117345_bib0027","article-title":"Prevalence of a cefazolin inoculum effect associated with blaZ gene types, and clinical outcomes among methicillin-susceptible Staphylococcus aureus blood isolates of patients with infective endocarditis","volume":"53","author":"Bourreau","year":"2023","journal-title":"Infect Dis Now"},{"key":"10.1016\/j.diagmicrobio.2026.117345_bib0028","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1093\/jac\/dkad263","article-title":"Treatment outcomes with benzylpenicillin and non-benzylpenicillin antibiotics, and the performance of the penicillin zone-edge test versus molecular detection of blaZ in penicillin-susceptible Staphylococcus aureus (PSSA) bacteraemia","volume":"78","author":"Mok","year":"2023","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2026.117345_bib0029","first-page":"3353","article-title":"Reappearance and treatment of penicillin-susceptible Staphylococcus aureus in a tertiary medical centre","volume":"70","author":"Chabot","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2026.117345_bib0030","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jiac.2019.10.023","article-title":"Comparison of penicillins (penicillin G and ampicillin) and cefazolin as a definitive therapy against penicillin-susceptible Staphylococcus aureus (PSSA) bacteremia in Japan: a retrospective cohort study","volume":"26","author":"Moriyama","year":"2020","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.diagmicrobio.2026.117345_bib0031","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jiac.2017.10.014","article-title":"Molecular epidemiology of \u03b2-lactamase production in penicillin-susceptible Staphylococcus aureus under high-susceptibility conditions","volume":"24","author":"Matono","year":"2018","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.diagmicrobio.2026.117345_bib0032","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/jac\/dkaf093","article-title":"Validation of a modified rapid test to detect the cefazolin inoculum effect in methicillin-susceptible Staphylococcus aureus from bloodstream infections in hospitals from North and Latin America","volume":"80","author":"Gomez-Villegas","year":"2025","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2026.117345_bib0033","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.51353","article-title":"\u0392-lactam inoculum effect in methicillin-susceptible Staphylococcus aureus infective endocarditis","volume":"7","author":"Jean","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.diagmicrobio.2026.117345_bib0034","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.cmi.2017.07.001","article-title":"Comparative outcomes of cefazolin versus nafcillin for methicillin-susceptible Staphylococcus aureus bacteraemia: a prospective multicentre cohort study in Korea","volume":"24","author":"Lee","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.diagmicrobio.2026.117345_bib0035","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s10096-018-3392-6","article-title":"Inoculum effect of methicillin-susceptible Staphylococcus aureus against broad-spectrum beta-lactam antibiotics","volume":"38","author":"Song","year":"2019","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2026.117345_bib0036","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/cid\/civ308","article-title":"Comparative effectiveness of beta-lactams versus vancomycin for treatment of methicillin-susceptible Staphylococcus aureus bloodstream infections among 122 hospitals","volume":"61","author":"McDanel","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2026.117345_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2021.106363","article-title":"Clinical outcomes of daptomycin versus anti-staphylococcal beta-lactams in definitive treatment of methicillin-susceptible Staphylococcus aureus bloodstream infections","volume":"58","author":"Agnello","year":"2021","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.diagmicrobio.2026.117345_bib0038","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1177\/10600280221115460","article-title":"Safety and efficacy of ceftriaxone in the treatment of methicillin-susceptible Staphylococcus aureus bloodstream infections: a noninferiority retrospective cohort study","volume":"57","author":"Ganguly","year":"2023","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.diagmicrobio.2026.117345_bib0039","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s10096-023-04575-z","article-title":"Post-treatment outcomes of ceftriaxone versus antistaphylococcal penicillins or cefazolin for definitive therapy of methicillin-susceptible Staphylococcus aureus bacteremia","volume":"42","author":"Yetmar","year":"2023","journal-title":"Eur J Clin Microbiol Infect Dis"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889326000957?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889326000957?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T18:08:57Z","timestamp":1777572537000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889326000957"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0732889326000957"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2026.117345","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigation of the cefazolin inoculum effect in blood culture-isolated methicillin-susceptible Staphylococcus aureus strains: A Japanese multicenter study","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2026.117345","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117345"}}